Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MyungMoon Pharm Co Ltd

+ Add to Watchlist

017180:KS

4,355 KRW 305 7.53%

As of 21:22:56 ET on 06/01/2015.

Snapshot for MyungMoon Pharm Co Ltd (017180)

Open: 4,150 Day's Range: 4,110 - 4,475 Volume: 1,878,169
Previous Close: 4,050 52wk Range: 2,107 - 4,475 1-Yr Rtn: +104.37%

Stock Chart for 017180

No chart data available.
  • 017180:KS 4,355
  • 1D
  • 1M
  • 1Y
4,050
Interactive 017180 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 017180

Current P/E Ratio (ttm) 95.2230
Estimated P/E(-) -
Relative P/E vs. KOSPI 5.5973
Earnings Per Share (ttm) 42.5317
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 73,345.50
Shares Outstanding (M) 18.11
30 Day Average Volume 1,751,659
Price/Book (mrq) 1.1352
Price/Sale (ttm) 0.7428
Dividend Indicated Gross Yield 0.43%
Cash Dividend (KRW) 17.3994
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -10.48%
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 017180

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 017180

Myungmoon Pharm. Co., Ltd. manufactures a variety of pharmaceutical products. The Company's major products include anesthetics, digestive, antitussive, and antibiotics.

Lee Kyu-HyukChairman/CEO/Co-Rep DirectorWoo Seok-MinPresident/Co-Rep Director
Bae Chul-HanVice PresidentPark Choon-SikSenior Managing Director
More Company Profile & Key Executives for 017180

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil